Reference SummaryTan M, Cell Rep 2022 Dec 20;41(12):111837

Title

The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model.

Authors

Tan M; Chang Y; Liu X; Li H; Tang Z; Nyati MK; Sun Y

Journal

Cell Rep

Volume

41

Issue

12

Year

2022

Pages

111837

Abstract

SAG/RBX2 is an E3 ligase, whereas SHOC2 is a RAS-RAF positive regulator. In this study, we address how Sag-Shoc2 crosstalk regulates pancreatic tumorigenesis induced by Kras(G12D). Sag deletion increases the size of pancreas and causes the conversion of murine pancreatic intraepithelial neoplasms (mPanINs) to neoplastic cystic lesions with a mechanism involving Shoc2 accumulation, suggesting that Sag determines the pathological process via targeting Shoc2. Shoc2 deletion significantly inhibits pancreas growth, mPanIN formation, and acinar cell transdifferentiation, indicating that Shoc2 is essential for Kras(G12D)-induced pancreatic tumorigenesis. Likewise, in a primary acinar 3D culture, Sag deletion inhibits acinar-to-ductal transdifferentiation, while Shoc2 deletion significantly reduces the duct-like structures. Mechanistically, SAG is an E3 ligase that targets SHOC2 for degradation to affect both Mapk and mTorc1 pathways. Shoc2 deletion completely rescues the phenotype of neoplastic cystic lesions induced by Sag deletion, indicating physiological relevance of the Sag-Shoc2 crosstalk. Thus, the Sag-Shoc2 axis specifies the pancreatic tumor types induced by Kras(G12D).

Links

J:332394 – MGI References
36543126 – National Library of Medicine/PubMed

Models

Strain Model Name Treatment Agent(s) Organ Affected Frequency Model Details
C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas - Acinar cell metaplasia - ductal Pancreas - Acinar cell

observed

SHN Pancreas - Acinar cell metaplasia - ductal Pancreas - Acinar cell

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas - Acinar cell metaplasia - ductal Pancreas - Acinar cell

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas adenocarcinoma - ductal Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas adenocarcinoma - ductal Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas adenocarcinoma - ductal Pancreas

0

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Rnf7tm1.1Ysun Pancreas adenocarcinoma - ductal Pancreas

0

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas cyst Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas dysplasia - low grade Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas hyperplasia Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas hyperplasia Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas hyperplasia Pancreas

0

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas lesion - cystic Pancreas

observed - 100

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas lesion - cystic Pancreas

0 - 10

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas lesion - cystic Pancreas

0

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Rnf7tm1.1Ysun Pancreas lesion - cystic Pancreas

0

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas lesion - neoplastic Pancreas

57 - 100

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas neoplasia - mucinous - papillary - intraductal Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas neoplasm - cystic - mucinous Pancreas

0

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas pancreatic intraepithelial neoplasia 1 (PanIN1) Pancreas

observed

SHN Pancreas pancreatic intraepithelial neoplasia 1 (PanIN1) Pancreas

observed

STOCK Tg(Wap-HRAS)69Lln Chr YSJL Pancreas pancreatic intraepithelial neoplasia 1 (PanIN1) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas pancreatic intraepithelial neoplasia 1 (PanIN1) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas pancreatic intraepithelial neoplasia 1 (PanIN1) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Rnf7tm1.1Ysun Pancreas pancreatic intraepithelial neoplasia 1 (PanIN1) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas pancreatic intraepithelial neoplasia 2 (PanIN2) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas pancreatic intraepithelial neoplasia 2 (PanIN2) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas pancreatic intraepithelial neoplasia 2 (PanIN2) PNS - Schwann cell

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas pancreatic intraepithelial neoplasia 2 (PanIN2) PNS - Schwann cell

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas pancreatic intraepithelial neoplasia 2 (PanIN2) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Rnf7tm1.1Ysun Pancreas pancreatic intraepithelial neoplasia 2 (PanIN2) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Pancreas pancreatic intraepithelial neoplasia 3 (PanIN3) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Rnf7tm1.1Ysun Pancreas pancreatic intraepithelial neoplasia 3 (PanIN3) Pancreas

observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Pancreas pancreatic intraepithelial neoplasia 3 (PanIN3) Pancreas

0 - observed

C57BL/6-Krastm4Tyj/+ Ptf1atm1.1(cre)Cvw/+ Shoc2tm1.1Mhan Rnf7tm1.1Ysun Pancreas pancreatic intraepithelial neoplasia 3 (PanIN3) Pancreas

0